Could cause temporary or reversible harm; serious harm is unlikely.
Labeling:Label Mixup; IRBESARTAN, Tablet, 150 mg may be potentially mislabeled as ATROPINE SULFATE/DIPHENOXYLATE HCL, Tablet, 0.025 mg/2.5 mg, NDC 00378041501, Pedigree: W003597, EXP: 6/24/2014; CHOLECALCIFEROL, Tablet, 400 units, NDC 00904582360, Pedigree: AD76686_7, EXP: 5/31/2014.
| Distributed by / for | AidaPak Service, LLC |
| NDC | 65862063830 |
| Full product label | IRBESARTAN, Tablet, 150 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 65862063830 |
| Recalling firm | Aidapak Services, LLC |
| Distribution | Repacked drugs were distributed in Arizona, California, Oregon, and Washington. |
| Quantity | 60 Tablets |
| Recall initiated | 2013-07-02 |
| Report date | 2014-01-22 |
| Recall completed | 2014-02-07 |
| Recall number | D-717-2014 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | Vancouver WA United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗